Published • loading... • Updated
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
Summary by Enid News & Eagle
4 Articles
4 Articles
Cyclerion Stock Hits 52-Week High on Korsana Merger Buzz
Cyclerion Therapeutics (NASDAQ: CYCN) saw its stock skyrocket on Wednesday, surging more than 300% during regular trading before extending gains in after-hours activity. At its peak, CYCN shares briefly touched a new 52-week high of $8.48 before settling near $6.35 by the close. This rally lifted the company’s market capitalization to approximately $24.68 million. Over the past week alone, the stock has climbed nearly 294%, according to Google F…
Coverage Details
Total News Sources4
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium

